The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Tumor necrosis factor‐α antagonists and neuropathy
Abstract
Tumor necrosis factor (TNF)‐α plays an important role in many aspects of immune system development, immune‐response regulation, and T‐cell–mediated tissue injury. The evidence that TNF‐α, released by autoreactive T cells and macrophages, may contribute to the pathogenesis of immune‐mediated demyelinating neuropathies is reviewed. TNF‐α antagonists (infliximab, etanercept, adalimumab) are indicated for the treatment of advanced inflammatory rheumatic and bowel disease, but these drugs can induce a range of autoimmune diseases that also attack the central and peripheral nervous systems. Case histories and series report on the association between anti–TNF‐α treatment and various disorders of peripheral nerve such as Guillain–Barré syndrome, Miller Fisher syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy with conduction block, mononeuropathy multiplex, and axonal sensorimotor polyneuropathies. The proposed pathogeneses of TNF‐α–associated neuropathies include both a T‐cell and humoral immune attack against peripheral nerve myelin, vasculitis‐induced nerve ischemia, and inhibition of signaling support for axons. Most neuropathies improve over a period of months by withdrawal of the TNF‐α antagonist, with or without additional immune‐modulating treatment. Preliminary observations suggest that TNF‐α antagonists may be useful as an antigen‐nonspecific treatment approach to immune‐mediated neuropathies in patients with a poor response to, or intolerance of, standard therapies, but further studies are required. Muscle Nerve, 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Animal models for autoimmune demyelinating disorders of the nervous system
Gold, R., Hartung, H.-P., & Toyka, K. V. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01639-1 · Cited by 292
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1573 · Cited by 287
Cited by
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Probert, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.038 · Cited by 495
Extraintestinal manifestations and complications in IBD
Ott, C., & Schölmerich, J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.117 · Cited by 351
Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases
Leyva-López, N., Gutierrez-Grijalva, E., Ambriz-Perez, D., & Heredia, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060921 · Cited by 337
Autoimmune diseases induced by biological agents
Ramos-Casals, M., Roberto-Perez-Alvarez, Diaz-Lagares, C., Cuadrado, M.-J., & Khamashta, M. A. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.10.003 · Cited by 323
Metadata
- Authors
- Stübgen, J.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2007-11-26
- Volume
- 37
- Issue
- 3
- Pages
- 281-292
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2105816635
- Cited by
- 236
- References
- 2
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor necrosis factor‐α antagonists and neuropathy. https://app.cochat.ai/papers/10.1002/mus.20924
- The paper
- Stübgen, J. (2008). Tumor necrosis factor‐α antagonists and neuropathy. Muscle & Nerve. https://doi.org/10.1002/mus.20924
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.